The Global Acute Migraine Drugs Market was valued at USD 1.29 billion in 2020 and is expected to reach USD 3.51 billion by the year 2028, at a CAGR of 13%. Migraine is a neurological disorder that includes headaches, nausea, impaired sense of smell, increased sensitivity to sound and light, and numbness. These headaches occur on one […]
